Expression of Concern: Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome

Expression of Concern: Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome

Bibliographic Details
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Gynecological Endocrinology
Online Access:	https://www.tandfonline.com/doi/10.1080/09513590.2024.2307189

Similar Items

#140 : Combined Use of Letrozole, Cabergoline and GnRH Antagonist to Prevent Ovarian Hyperstimulation Syndrome Completely in Polycystic Ovarian Syndrome Treatment
by: Yasuho Yanagihara, et al.
Published: (2023-12-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016-05-01)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
by: Yasuho Yanagihara, et al.
Published: (2022-01-01)

Meta-analysis of trigger timing in normal responders undergoing GnRH antagonist ovarian hyperstimulation protocol
by: Qijun Xie, et al.
Published: (2024-03-01)

The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer
by: Jing-Shuang Zhou, et al.
Published: (2023-08-01)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
by: Raoul Orvieto
Published: (2023-01-01)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
by: Mu Lv, et al.
Published: (2022-10-01)

Comparing ART outcomes in women with endometriosis after GnRH agonist GnRH antagonist ovarian stimulation: a systematic review
by: Kevin K.W. Kuan, et al.
Published: (2023-07-01)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
by: Erkan Kalafat, et al.
Published: (2022-05-01)

The use of cabergoline for treatment of syndrome of ovarian hyperstimulation
Published: (2012-12-01)

A prediction model for high ovarian response in the GnRH antagonist protocol
by: Yilin Jiang, et al.
Published: (2023-11-01)

Long GnRH Agonist versus GnRH Antagonist Protocols in Women with Endometrioma and Good Ovarian Reserve Undergoing IVF/ICSI Cycles
by: Maryam Eftekhar, et al.
Published: (2023-01-01)

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.
by: Ming-Chao Huang, et al.
Published: (2018-01-01)

Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide
by: Camargos Aroldo F, et al.
Published: (2010-05-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

#101 : A Direct Healthcare Cost Analysis of Recombinant LH Versus hMG Supplementation on FSH During Controlled Ovarian Hyperstimulation in the GnRH-Antagonist Protocol
by: Jui-Chun Chang, et al.
Published: (2023-12-01)

A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
by: Ming-Jer Chen, et al.
Published: (2022-08-01)

Comparison of two different starting dose of rhFSH in GnRH antagonist protocol for patients with normal ovarian reserve
by: Zhi-cheng Jia, et al.
Published: (2023-01-01)

Comparing progesterone primed ovarian stimulation (PPOS) to GnRH antagonist protocol in oocyte donation cycles
by: Rupali Khaparde Khurana, et al.
Published: (2022-01-01)

Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
by: Tien K. Le, et al.
Published: (2024-03-01)

Corrigendum: A retrospective, matched case-control study of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol
by: Ming-Jer Chen, et al.
Published: (2022-12-01)

Pregnancy outcomes in PCOS patients undergoing IVF with long GnRH agonist protocol versus flexible GnRH antagonist
by: Nayereh Khadem Ghaebi, et al.
Published: (2018-11-01)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
by: Madelaine J. Cho-Clark, et al.
Published: (2023-04-01)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
by: Colleen A. Flanagan, et al.
Published: (2017-10-01)

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers
by: Maritza P. Garrido, et al.
Published: (2023-03-01)

Clinical study of GnRH-a treatment after operation of ovarian endometrioma
by: WANG Wei, et al.
Published: (2022-12-01)

Investigation of the GnRH antagonist degarelix isomerization in biological matrices
by: Lucia Ferrazzano, et al.
Published: (2023-08-01)

#304 : Comparing GnRH Agonist and GnRH Antagonist Protocols for IVF-ET Outcomes in Patients with Endometriosis: A Meta-Analysis
by: Haerin Paik, et al.
Published: (2023-12-01)

Ovarian hyperstimulation syndrome following the use of GnRH agonist trigger of final oocyte maturation and freeze-all strategy: A case report and review of the literature
by: Dalia Khalife, et al.
Published: (2022-01-01)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
by: Jifan Tan, et al.
Published: (2023-02-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Weaned Sows with Small Ovarian Follicles Respond Poorly to the GnRH Agonist Buserelin
by: Tania P. Lopes, et al.
Published: (2020-10-01)

Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
by: Le Duc Thang, et al.
Published: (2024-04-01)

Repeated application of luteal phase oestradiol/GnRH antagonist priming increases IVF success for poor ovarian reserve patients
by: Temel Ceyhan, et al.
Published: (2023-12-01)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
by: Zhu Shaomi, et al.
Published: (2022-11-01)

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety
by: Jieru Zhu, et al.
Published: (2022-06-01)

Invitro fertilization outcome in triggering with GnRH agonist, Hcg or combination of GnRH agonist and Hcg
by: Alamtaj Samsami, et al.
Published: (2020-11-01)

Effect of a GnRH agonist (deslorelin) on ovarian activity in leopard geckos (Eublepharis macularius)
by: Eva Cermakova, et al.
Published: (2019-05-01)

Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study
by: Juan Gui, et al.
Published: (2022-12-01)

Evaluation of the Impact of Letrozole in Combination with the GnRH Antagonist Ovarian Stimulation Protocol in Patients Expected to Have a Poor Ovarian Response (POSEIDON Groups 3 and 4)
by: Bulut Varlı, et al.
Published: (2024-02-01)